Postpartum hemorrhage in developing countries: is the public health community using the right tools?

Objectives: To identify new and underutilized technologies that may assist in reducing maternal mortality due to obstetric hemorrhage. Methods: Review of published and unpublished literature, including systematic reviews of randomized trials and individual clinical studies. Results: Hemorrhage, prim...

Full description

Saved in:
Bibliographic Details
Published in:International journal of gynecology and obstetrics 2004-06, Vol.85 (S1), p.S42-S51
Main Authors: Tsu, V.D., Langer, A., Aldrich, T.
Format: Article
Language:English
Subjects:
Developing Countries
Female
Health Services Accessibility
Humans
Maternal Health Services - organization & administration
Maternal Mortality
Medically Underserved Area
Misoprostol
Oxytocics - administration & dosage
Oxytocin
Postpartum hemorrhage
Postpartum Hemorrhage - prevention & control
Pregnancy
Randomized Controlled Trials as Topic
Third-stage labor
Uniject
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives: To identify new and underutilized technologies that may assist in reducing maternal mortality due to obstetric hemorrhage. Methods: Review of published and unpublished literature, including systematic reviews of randomized trials and individual clinical studies. Results: Hemorrhage, primarily postpartum, accounts for approximately 25% of maternal deaths globally. Uterotonic drugs offer great promise for both prevention and management of postpartum hemorrhage (PPH). Other technologies—such as anti-shock garments, umbilical vein injection of oxytocin, and simple anemia detection methods—represent potential new opportunities to reduce PPH-related mortality. Conclusions: Clinical and operational research is needed to answer remaining questions about misoprostol, the anti-shock garment, and umbilical vein injection of oxytocin for retained placenta. Efforts are needed to ensure the availability of technologies with proven value, such as oxytocin in Uniject™ prefilled injection devices. Equally important, technologies and techniques with proven efficacy—such as active management of third-stage labor and aortic compression—must be translated into general use by disseminating the evidence for them, incorporating them into national guidelines and training curricula, and ensuring the availability of supportive supplies and equipment.
ISSN:0020-7292
1879-3479
DOI:10.1016/j.ijgo.2004.02.009